Display Settings:

Format

Send to:

Choose Destination
Neurology. 2009 Oct 27;73(17):1406-12. doi: 10.1212/WNL.0b013e3181beecfe. Epub 2009 Sep 23.

Responding to requests from adult patients for neuroenhancements: guidance of the Ethics, Law and Humanities Committee.

Author information

  • 1Department of Neurology and School of Law, University of Virginia, Charlottesville, VA 22908, USA. dgl6t@virginia.edu

Abstract

In the last decade, persons who have no diagnosed medical or mental health condition are increasingly seeking and utilizing, for the ostensible purpose of enhancing their memory or cognitive skills, prescription drugs that were originally developed to improve executive function or memory in persons diagnosed with disorders such as attention deficit hyperactivity disorder or Alzheimer disease. Evidence suggests that this practice, now known as neuroenhancement, is gathering momentum. As a result, neurologists may be encountering patients without a diagnosed illness asking for medications with the goal of improving their memory, cognitive focus, or attention span. Strong arguments have been made for and against this practice, often reflecting strongly held convictions concerning the appropriate practice of medicine. The purpose of this report is to provide neurologists with an overview of the ethical, legal, and social issues surrounding the use of pharmaceuticals prescribed to enhance or augment normal cognitive or affective functioning, as well as practical guidance for responding to an adult patient's request for neuroenhancement.

PMID:
19776378
[PubMed - indexed for MEDLINE]
PMCID:
PMC2769556
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for HighWire Icon for PubMed Central
    Loading ...
    Write to the Help Desk